Vaccine Production and Generics Surge

The African Development Bank is providing $15 million to Biovac in South Africa, boosting vaccine manufacturing capacity to 500 million doses annually and creating 340 jobs. Concurrently, the South African Health Products Regulatory Authority is reviewing twelve applications for generic semaglutide.

Country

Phone*

First Name*

Last Name*

Email*

Message*

We value and respect your privacy. By continuing, you agree to Sa Investment Corridor data protection policy.

I agree to be contacted back.

Security Check*

6 + 1 =

Solve the math question to enable the submit button.

💬

Live Message

LIVE

Hello! 👋 How can we help you?

Your Message

Please write a message first.

✅ Please share your details below

Name

Please enter your name.

Phone Number

Please enter your phone number.

Email (optional)

Preferred Communication

📱 WhatsApp 📞 Call 📧 Email

Please select at least one communication method.

✅

Thank you!

We have received your message.
One of our team members will contact you shortly at your preferred communication mode.

Please contact us for further information

Live Message